Selective pressures for and against genetic instability in cancer: A time-dependent problem

Institute for Genomics and Bioinformatics, University of California, Irvine, Irvine, California, United States
Journal of The Royal Society Interface (Impact Factor: 3.92). 02/2008; 5(18):105-21. DOI: 10.1098/rsif.2007.1054
Source: PubMed


Genetic instability in cancer is a two-edge sword. It can both increase the rate of cancer progression (by increasing the probability of cancerous mutations) and decrease the rate of cancer growth (by imposing a large death toll on dividing cells). Two of the many selective pressures acting upon a tumour, the need for variability and the need to minimize deleterious mutations, affect the tumour's 'choice' of a stable or unstable 'strategy'. As cancer progresses, the balance of the two pressures will change. In this paper, we examine how the optimal strategy of cancerous cells is shaped by the changing selective pressures. We consider the two most common patterns in multistage carcinogenesis: the activation of an oncogene (a one-step process) and an inactivation of a tumour-suppressor gene (a two-step process). For these, we formulate an optimal control problem for the mutation rate in cancer cells. We then develop a method to find optimal time-dependent strategies. It turns out that for a wide range of parameters, the most successful strategy is to start with a high rate of mutations and then switch to stability. This agrees with the growing biological evidence that genetic instability, prevalent in early cancers, turns into stability later on in the progression. We also identify parameter regimes where it is advantageous to keep stable (or unstable) constantly throughout the growth.

Download full-text


Available from: Alexander Sadovsky
  • Source
    • "This theory has been extensively used in economics and engineering (Kirk, 2004; Koo, 1977). Previous applications of optimal control theory in biology included an analysis of the response of the immune system to an antigen (Perelson et al., 1976), mutation rates in cancer (Komarova et al., 2008) and reproduction strategies of social insects (Macevicz and Oster, 1976). This latter problem, which has some similarities with the crypt developmental problem, considered the optimal choice that queen wasps dynamically make throughout a reproductive season between producing workers, which increase the nest's resources but do not reproduce, and reproductive nonworking progeny, with the aim of maximizing the reproductive progeny at the end of the season (Macevicz and Oster, 1976). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Intestinal crypts in mammals are comprised of long-lived stem cells and shorter-lived progenies. These two populations are maintained in specific proportions during adult life. Here, we investigate the design principles governing the dynamics of these proportions during crypt morphogenesis. Using optimal control theory, we show that a proliferation strategy known as a "bang-bang" control minimizes the time to obtain a mature crypt. This strategy consists of a surge of symmetric stem cell divisions, establishing the entire stem cell pool first, followed by a sharp transition to strictly asymmetric stem cell divisions, producing nonstem cells with a delay. We validate these predictions using lineage tracing and single-molecule fluorescence in situ hybridization of intestinal crypts in infant mice, uncovering small crypts that are entirely composed of Lgr5-labeled stem cells, which become a minority as crypts continue to grow. Our approach can be used to uncover similar design principles in other developmental systems.
    Full-text · Article · Feb 2012 · Cell
  • Source
    • "Recently Araujo and McElwain [6] have studied vascular collapse in relation to tumor growth rate, which has a direct effect on delivery of nutrients and delivery of anti-cancer drugs. Komarova et al. [7] have applied optimal control theory to formulate a theory in which the genetic instability and mutation within cancer cells lead to the decreased proliferation and self-limiting growth observed in solid tumors. Accurate models to describe tumor growth can lead to increased understanding of the growth dynamics and to improvements in understanding of tumor growth and improvements in treatment regimes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: An understanding of growth dynamics of tumors is important in understanding progression of cancer and designing appropriate treatment strategies. We perform a comparative study of the hyperbolastic growth models with the Weibull and Gompertz models, which are prevalently used in the field of tumor growth. The hyperbolastic growth models H1, H2, and H3 are applied to growth of solid Ehrlich carcinoma under several different treatments. These are compared with results from Gompertz and Weibull models for the combined treatment. The growth dynamics of the solid Ehrlich carcinoma with the combined treatment are studied using models H1, H2, and H3, and the models are highly accurate in representing the growth. The growth dynamics are also compared with the untreated tumor, the tumor treated with only iodoacetate, and the tumor treated with only dimethylsulfoxide, and the combined treatment. The hyperbolastic models prove to be effective in representing and analyzing the growth dynamics of the solid Ehrlich carcinoma. These models are more precise than Gompertz and Weibull and show less error for this data set. The precision of H3 allows for its use in a comparative analysis of tumor growth rates between the various treatments.
    Full-text · Article · Sep 2010 · BMC Cancer
  • Source
    • "Maley et al. [22] have demonstrated that clonal diversity predicts progression to cancer and that accumulation of viable clonal genetic variants is a greater risk for progressing to cancer than homogenizing clonal expansion . Mathematical model by Komarova et al. [10] shows that tumors thrive when cancerous cells mutate to speed up malignant transformation, and then stay that way by turning off the mutation rate. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Any process in which competing solutions replicate with errors and numbers of their copies depend on their respective fitnesses is the evolutionary optimization process. As during carcinogenesis mutated genomes replicate according to their respective qualities, carcinogenesis obviously qualifies as the evolutionary optimization process and conforms to common mathematical basis. The optimization view accents statistical nature of carcinogenesis proposing that during it the crucial role is actually played by the allocation of trials. Optimal allocation of trials requires reliable schemas' fitnesses estimations which necessitate appropriate, fitness landscape dependent, statistics of population. In the spirit of the applied conceptual framework, features which are known to decrease efficiency of any evolutionary optimization procedure (or inhibit it completely) are anticipated as "therapies" and reviewed. Strict adherence to the evolutionary optimization framework leads us to some counterintuitive implications which are, however, in agreement with recent experimental findings, such as sometimes observed more aggressive and malignant growth of therapy surviving cancer cells.
    Full-text · Article · Nov 2009 · Medical Hypotheses
Show more

Similar Publications